ImaSight Corp. announced that it is temporarily shutting down its Liponex division to conserve capital in the current economic turmoil. Previously announced efforts to license the company's technology are continuing.

In another cost cutting move, Brian Radburn will be leaving as CFO. John Brooks, CEO, will assume the interim CFO duties and Jean Caseault, President, will be promoted to President and co-CEO.

"While reducing costs is the prudent thing to do in this uncertain economic environment," said Brooks, "we are encouraged that booked installations of our digital x-ray sensor indicate that November will be our best ever month. This growth comes primarily from Canadian sales. We are now well positioned once the economic conditions in the US stabilize."

About ImaSight
ImaSight markets its patented digital x-ray sensor at a price affordable to veterinarians and chiropractors. Its hospital grade sensor has been approved for sale by Health Canada. Its Liponex division is developing natural source products for the treatment of cholesterol. Further information can be found at www.imasight.com

More Voices